Exclusive: Kotak's PIPE fund bets on Mumbai-based pharma firm

January 16, 2017 | Bruhadeeswaran R

Kotak Private Equity, the alternative asset investment arm of India’s fourth-largest private lender Kotak Mahindra Bank, has picked a stake in a pharmaceuticals company that manufactures and markets formulations and active pharmaceutical ingredients (APIs) in India.

BCCL's Brand Capital backs nutritional supplements maker Genmedic Healthcare

January 11, 2017 | Joseph Rai

Genmedic Healthcare Pvt Ltd, which makes vegetarian nutritional supplements under the Super Gummy brand, on Wednesday said it has raised an undisclosed amount from ad-for-equity investment arm of media firm Bennett, Coleman and Company Ltd (BCCL), Brand Capital.

Former Dr. Reddy's exec-led Slayback Pharma raises $60 mn from KKR

January 09, 2017 | Joseph Rai

Slayback Pharma, LLC, a privately held pharmaceutical company founded by a former executive of Indian drugmaker Dr. Reddy's Laboratories Ltd, has raised $60 million (around Rs 400 crore) from global investment firm KKR, it said in a statement.

Aurobindo Pharma to buy Portugal's Generis Farmaceutica for $142 mn

January 07, 2017 | Joseph Rai

Drugmaker Aurobindo Pharma Ltd said on Saturday that it has agreed to acquire Portugal-based pharmaceuticals products and supplier Generis Farmaceutica SA from private equity firm Magnum Capital Partners for €135 million (Rs 969 crore or $142 million) in an all cash deal.

Exclusive: Healthcare firm Sanzyme hires banker for fundraise

December 29, 2016 | Ranjani Raghavan

Sanzyme Pvt. Ltd, a Hyderabad-based pharmaceuticals company, has hired an investment bank for its first external fund raise, two people familiar with the development said.

Zydus Cadila acquires six brands from Merck

December 29, 2016 | Joseph Rai

Drugmaker Cadila Healthcare, which operates under the brand Zydus Cadila, said it has acquired six brands from global drug giant Merck for an undisclosed amount as the company seeks to strengthen its portfolio in the therapeutic segment.

TA Associates invests $25.5 mn in Shilpa Medicare

December 26, 2016 | Ranjani Raghavan

US-based private equity investor TA Associates Management Lp has invested Rs 172.425 crore ($25.5 million) in drug ingredients maker Shilpa Medicare Ltd.

Sun Pharma acquires 14.58% stake in scPharmaceuticals for $13 mn

December 23, 2016 | Ranjani Raghavan

Drugmaker Sun Pharmaceutical Industries Ltd has acquired a stake in US-based pharmaceuticals company scPharmaceuticals Inc for $13 million, the firm told stock exchanges on Friday.

Morgan Stanley PE invests in ZCL Chemicals

December 22, 2016 | Ranjani Raghavan

Morgan Stanley Private Equity Asia has invested Rs 170 crore ($25 million) in Mumbai-based pharmaceutical company ZCL Chemicals Ltd, a press statement said.

Sun Pharma to acquire cancer drug from Novartis for $175 mn

December 22, 2016 | TEAM VCC

Sun Pharmaceutical Industries Ltd, India’s biggest drugmaker, plans to acquire skin cancer drug Odomzo from Swiss firm Novartis AG for an upfront payment of $175 million (Rs 1,190 crore).



Upcoming Events